🇺🇸 FDA
Patent

US 10675348

Antibodies that bind human C6 and uses thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10675348 (Antibodies that bind human C6 and uses thereof) held by REGENESANCE B.V. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENESANCE B.V.
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K38/02, A61K39/395